Somasundaram R, Ruehl M, Tiling N, Ackermann R, Schmid M, Riecken E O, Schuppan D
Department of Gastroenterology and Hepatology, Klinikum Benjamin Franklin, Free University of Berlin, Berlin, Germany.
J Biol Chem. 2000 Dec 8;275(49):38170-5. doi: 10.1074/jbc.M006616200.
The binding of certain growth factors and cytokines to components of the extracellular matrix can regulate their local availability and modulate their biological activities. We show that interleukin 2 (IL-2), an important stimulator of T cell growth, preferentially binds to collagen types I, III, and VI and to a lesser degree to collagen types II, IV, and V, immobilized on polystyrene or nitrocellulose. These interactions are inhibited by denatured, single collagen chains or a subset of their cyanogen bromide peptides in a dose-dependent manner. Cross-inhibition experiments and ligand blotting of collagen-derived peptides point to a limited set of collagenous consensus sequences mediating the binding of IL-2. This interaction is saturable, with dissociation constants of approximately 10(-)(8) m, and estimated molar ratios of 4-6 molecules of IL-2 bound to one molecule of triple helical collagen. Furthermore, collagen-bound IL-2 stimulates proliferation of mouse lymphocytes. We conclude that its specific binding to the abundant interstitial collagens leads to a spatial pattern of bioavailable IL-2 which is dictated by the local organization of the collagenous extracellular matrix. This interaction may contribute to the particular phenotype of stromal lymphocytes and could be exploited for devising collagenous peptide analogues that modulate IL-2 bioactivity.
某些生长因子和细胞因子与细胞外基质成分的结合可调节它们在局部的可用性并调节其生物学活性。我们发现,作为T细胞生长的重要刺激因子,白细胞介素2(IL-2)优先结合固定在聚苯乙烯或硝酸纤维素上的I型、III型和VI型胶原蛋白,与II型、IV型和V型胶原蛋白的结合程度较低。这些相互作用受到变性的单链胶原蛋白或其溴化氰肽的一个子集的剂量依赖性抑制。胶原蛋白衍生肽的交叉抑制实验和配体印迹表明,介导IL-2结合的胶原蛋白共有序列有限。这种相互作用是可饱和的,解离常数约为10^(-8) m,估计IL-2与一分子三螺旋胶原蛋白结合的摩尔比为4至6个分子。此外,结合胶原蛋白的IL-2刺激小鼠淋巴细胞增殖。我们得出结论,其与丰富的间质胶原蛋白的特异性结合导致了生物可利用的IL-2的空间模式,这是由胶原蛋白细胞外基质的局部组织决定的。这种相互作用可能有助于基质淋巴细胞的特定表型,并可用于设计调节IL-2生物活性的胶原蛋白肽类似物。